🇺🇸 FDA
Patent

US 6815425

Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same

expired A61KA61K38/06A61K45/06

Quick answer

US patent 6815425 (Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same) held by The United States of America as represented by the Secretary of the Army expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Nov 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/06, A61K45/06